Additional file 1 of Urinary polycyclic aromatic hydrocarbon metabolites and hyperlipidemia: NHANES 2007–2016

Additional file 1: Table S1. Detection rates of 6 urinary PAHs metabolites; Table S2. Information of each quartile for different urinary PAHs metabolites; Table S3. Stratified Variables Illuminate the Association of 1-Hydroxynaphthalene with Hyperlipidemia in the US Population; Table S4. Stratified Variables Illuminate the Association of 2-Hydroxynaphthalene with Hyperlipidemia in the US Population; Table S5. Stratified Variables Illuminate the Association of 3-Hydroxyfluorene with Hyperlipidemia in the US Population; Table S6. Stratified Variables Illuminate the Association of 2-Hydroxyfluorene with Hyperlipidemia in the US Population; Table S7. Stratified Variables Illuminate the Association of 1-Hydroxyphenanthrene with Hyperlipidemia in the US Population; Table S8. Stratified Variables Illuminate the Association of 1-Hydroxypyrene with Hyperlipidemia in the US Population; Table S9. The joint effect of urinary PAHs metabolites mixtures on the prevalence of hyperlipidemia in WQS model in positive and negative direction.